22nd Century Group (NYSEAMERICAN:XXII) released its quarterly earnings results on Wednesday. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter, MarketWatch Earnings reports. The business had revenue of $6.26 million for the quarter.
Shares of XXII stock traded down $0.10 during trading hours on Thursday, hitting $2.57. 76,759 shares of the company’s stock traded hands, compared to its average volume of 2,485,598. 22nd Century Group has a 12 month low of $1.92 and a 12 month high of $4.44.
Separately, Zacks Investment Research downgraded shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Thursday, August 16th.
TRADEMARK VIOLATION WARNING: “22nd Century Group (XXII) Releases Quarterly Earnings Results” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://sportsperspectives.com/2018/11/08/22nd-century-group-xxii-releases-quarterly-earnings-results.html.
22nd Century Group Company Profile
22nd Century Group, Inc, a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies.
Further Reading: Does the discount rate affect the economy?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.